Publications in collaboration with researchers from Stanford University (32)

2024

  1. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

    Schizophrenia bulletin, Vol. 50, Núm. 3, pp. 496-512

  2. In Reply to the “Letter to the Editor Regarding: Virtual Reality During Brain Mapping for Awake-Patient Brain Tumor Surgery: Proposed Tasks and Domains to Test”

    World Neurosurgery

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. A 6-mRNA host response classifier in whole blood predicts outcomes in COVID-19 and other acute viral infections

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Fuzzy Matching for Cellular Signaling Networks in a Choroidal Melanoma Model

    Advances in Intelligent Systems and Computing

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials

    Leukemia, Vol. 35, Núm. 1, pp. 18-30

  4. NADPH oxidase 4 (Nox4) deletion accelerates liver regeneration in mice

    Redox Biology, Vol. 40

  5. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

    The Lancet Oncology, Vol. 22, Núm. 3, pp. e105-e118

  6. Virtual Reality During Brain Mapping for Awake-Patient Brain Tumor Surgery: Proposed Tasks and Domains to Test

    World Neurosurgery, Vol. 152, pp. e462-e466

2019

  1. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973

  2. LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL

    Cancer Cell, Vol. 36, Núm. 3, pp. 237-249.e6

  3. Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions

    Haematologica, Vol. 104, Núm. 10, pp. 1935-1949

  4. STS, ESTS and JACS survey on surveillance practices after surgical resection of lung cancer

    Interactive cardiovascular and thoracic surgery, Vol. 29, Núm. 4, pp. 532-538

  5. Society for Translational Medicine Expert consensus on the selection of surgical approaches in the management of thoracic esophageal carcinoma

    Journal of Thoracic Disease, Vol. 11, Núm. 1, pp. 319-328

2018

  1. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

    The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204

2017

  1. Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions

    Oncotarget, Vol. 8, Núm. 43, pp. 73483-73500

2016

  1. Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia

    Leukemia

  2. Dietary and microbiome factors determine longevity in Caenorhabditis elegans

    Aging, Vol. 8, Núm. 7, pp. 1513-1539

  3. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy